News – Page 2 – Endpoints News

Endpoints News is getting a new web address: https://endpoints.news

3 days ago

Publisher's note

Post-Hoc: AI bio needs to heed the overhyped history of CRISPR

3 days ago

Samsung Biologics to separate manufacturing and biosimilar businesses

3 days ago

Self-guided mental health apps can improve outcomes and lower costs, report finds

3 days ago

Sanofi makes $470M move for Vigil's Alzheimer's drug, while another asset returns to Amgen

3 days ago

FDA adcomm votes unanimously against Pfizer's prostate cancer drug combo

3 days ago

Hinge Health is going public on Thursday at a $3B valuation

3 days ago

FDA asks Covid vaccine makers to add more myocarditis data to labels

3 days ago

FDA announces efforts to facilitate drug importation from Canada

3 days ago

Teva, Novartis get fresh warnings from FTC over Orange Book patent listings

3 days ago

Updated: Eikon Therapeutics cuts staff for the second time in less than two years

3 days ago

FDA adcomm narrowly votes against UroGen’s bladder cancer drug, calls for RCTs

3 days ago

BioNTech invests £1B in growing UK footprint under expanded pact with government

3 days ago

Big leases, bigger regrets: Biotech slump turns swanky offices from asset into liability

3 days ago

Moderna pulls application for Covid-flu shot; Another IPO in Hong Kong

4 days ago

Cocaine vaccine, a longshot attempt to quell cravings, yields mixed data in small study

4 days ago

Shutting down a dementia care startup

4 days ago

Genentech expands deal with molecular glue biotech Orionis for $105M upfront

4 days ago

How PureTech’s lung fibrosis drug stacks up against the competition

4 days ago

Altos Labs buys anti-aging startup Dorian Therapeutics

4 days ago

Reproductive health biotech snags $65M to develop former Novartis and Merck KGaA drugs

4 days ago

UK biotech Juvenescence targets $150M+ for 'healthy lifespan' drug candidates

4 days ago

In his first major policy rollout, Vinay Prasad looks to challenge existing 'dogma' on Covid vaccines

4 days ago

Updated: FDA adcomm splits votes on Genentech and J&J cancer drugs

4 days ago

First page Previous page 123 4 5 Next page Last page